![Michael York](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael York
Plus aucun poste en cours
Profil
Michael York formerly worked at Metacrine, Inc., as President, CEO, CFO, Secretary & Treasurer in 2023, SENTÉ Labs, as President & Chief Executive Officer, Senté, Inc., as President & Chief Executive Officer from 2013 to 2014, Amylin Pharmaceuticals, Inc., as Vice President-Specialty & Rare Disease Unit, PhaseBio Pharmaceuticals, Inc., as Vice President-Development & Commercial Strategy, and Orexigen Therapeutics, Inc., as Vice President-Global Business Development from 2015 to 2018.
Mr. York received his undergraduate degree from San Diego State University and Masters Business Admin degree from the University of Redlands.
Anciens postes connus de Michael York
| Sociétés | Poste | Fin |
|---|---|---|
| METACRINE, INC. | Directeur Général | 24/03/2023 |
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2021 |
| OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2018 |
SENTÉ, Inc. (California)
 SENTÉ, Inc. (California) Specialty StoresRetail Trade Retails skin care products through online | Directeur Général | 01/12/2014 |
SENTÉ Labs | Directeur Général | - |
Formation de Michael York
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Redlands
 University of Redlands Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SENTÉ, Inc. (California)
SENTÉ, Inc. (California) Specialty StoresRetail Trade Retails skin care products through online | Retail Trade |
Metacrine, Inc.
 Metacrine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
SENTÉ Labs |
